This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Charles River Laboratories 5.50% 2026-04 USD

New bond issue: Charles River Laboratories (NYSE:CRL) issued new debt notes (USU14144AA41, U14144AA4) (144A: US159864AC13, 159864AC1) for 500M USD as of March 29, 2018. Tradable at TRACE OTC as of March 29, 2018. Listed at Berlin Stock Exchange as of April 3, 2018.

Charles River Laboratories International, Inc. is an American company providing products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics. It is headquartered in Wilmington, Massachusetts, United States.

IssuerCharles River Laboratories
Stock (Group)NYSE:CRL
Bond TypeCorporate
CategorySenior, Callable
Maturity DateApril 1, 2026
Residual Duration4 years, 6 months, 12 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)5.500%
Coupon FrequencySemiannual
Minimum Lot2,000 USD
Additional Lots1,000 USD
Issue DateApril 3, 2018
Issued Amount500,000,000 USD
Issue Price100.000%
Maturity Price100.000%
Bond RatingBB+ (S&P), B1 (Moody's)
Home ExchangeTRACE
Other ExchangesBerlin
Isin 144AUS159864AC13 (144A)
Cusip 144A159864AC1 (144A)
IndustryHealth Care Providers & Services
SectorHealth Care
CountryUnited States
RegionAmerica developed

Bonds, Corporate, Health Care, Health Care Providers & Services, America developed, United States, USD, Fixed Rate, Income

Next Neopost FFLR% Perpetual EUR